Tigecycline (Tygacil)

C. diff Risk

Medium

Oral Bioavailability

NA

Approximate Cost

Dosing

Severe Impairment - Child Pugh C
100mg load on day 1 then 25mg IV q12h

100mg IV load on day 1 then 50mg IV q12h

No dosing adjustment necessary

This medication is currently not on hospital formulary - please contact pharmacy if it is needed.

General Information

Common Usage

Reserved for highly resistant infections or when significant allergies restrict other options and when there is documented susceptibility.

Associated with more treatment failures than alternatives and excess mortality - Black Box Warning.

Adverse Effects

  • Avoid or use with caution in patients with tetracycline reactions.

  • GI side effects very prominent with significant nausea and vomiting.

  • Tetracycline related adverse events: photosensitivity, acute pancreatitis.

  • Rash, abnormal liver enzymes.

Major Interactions

Oral contraceptives less effective.

Additional Information

Requires Infectious Disease consultation.

Documented safety concerns in bacteremia especially.

Pharmacology

Antimicrobial class: Tetracycline derivative

Pregnancy category: D

Average serum half life: 42 hours

Lung penetration: Therapeutic

Biliary penetration: Therapeutic